MIP 1a
Alternative Names: Small inducible cytokine A3, SCYA3, chemokine (C-C motif) ligand 3, CCL3, Macrophage inflammatory protein 1-alpha, MIP-1-alpha, MIP1A, Tonsillar lymphocyte LD78 alpha protein, LD78ALPHA, G0/G1 switch regulatory protein 19-1, G0S19-1, G0S19-1 protein, SIS-beta, PAT 464.1.
- Sku: PSB-chm-233-5µg
- Vendor: ProSpec-Tany
Contact us directly for international purchases.
Product Description
Recombinant Human Macrophage Inflammatory protein-1 alpha (CCL3) is a chemokine belonging to the CC subfamily. With a molecular weight of approximately 8 kDa, CCL3 plays a role in the regulation of inflammatory responses by attracting and activating monocytes, T cells, and NK cells to sites of infection or tissue damage. This chemokine is involved in the recruitment and activation of immune cells, contributing to the body's defense mechanisms against pathogens and foreign invaders.
Current Lead Time
7-14 Days
Product Specifications
Species |
Human |
Expression System | E. coli |
Purity | 98% by SDS-PAGE |
Activity |
The Activity is calculated by the ability of chemo-attraction of Human monocytes using 1-10ng/ml corresponding to a Specific Activity of 100,000-1,000,000IU/mg. The Activity is calculated by the ability of chemo-attraction of Human monocytes using 1-10ng/ml corresponding to a Specific Activity of 100,000-1,000,000IU/mg. |
Activity Assay | |
Animal Component Free (ACF) | Yes |
Molecular Weight |
N/A |
Structure | Homodimer |
Endotoxin Concentration |
Not Available |
Purification Method | Not Available |
Form |
Lyophilized |
Formulation | The protein was lyophilized from 0.55 mg/ml solution containing no additives. |
*For Research Use Only
If your product is within its expiration period, and has not performed according to expectations, fill out the sample return form. Return the unused sample frozen, with the auto generated packing slip to the address on the instructions. You will receive a full refund along with a replacement of the unused portion (inclusive of the failed test). Damages do not cover any additional costs incurred for failed experimentation.
Have a question?
MIP 1a